Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection (Q40186025)
Jump to navigation
Jump to search
scientific article published on 22 May 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection |
scientific article published on 22 May 2017 |
Statements
1 reference
Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection (English)
1 reference
Stefan Wirth
1 reference
Philip Rosenthal
1 reference
Regino P Gonzalez-Peralta
1 reference
Maureen M Jonas
1 reference
William F Balistreri
1 reference
Chuan-Hao Lin
1 reference
Winita Hardikar
1 reference
Kathryn Kersey
1 reference
Benedetta Massetto
1 reference
Bittoo Kanwar
1 reference
Diana M Brainard
1 reference
Jiang Shao
1 reference
Evguenia Svarovskaia
1 reference
Brian Kirby
1 reference
Ronen Arnon
1 reference
Karen F Murray
1 reference
Kathleen B Schwarz
1 reference
22 May 2017
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference